Get the full picture
Sign in to uncover key details.
Show More
Edesa Biotech
Chemicals & Related Products · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Spy Crt, Markham, Ontario, L3R 5H6, ...Phone Number
(289) 800-9600Website
www.edesabiotech.comRevenue
<$5 MillionStock Symbol
EDSAIndustry
About Edesa Biotech
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing novel treatments for immune and inflammatory diseases. Their innovative monoclonal antibody candidates aim to address immune dysregulation through host-directed therapeutics. The company is dedicated to improving the lives of patients suffering from both acute and chronic conditions, with a particular emphasis on conditions like Acute Respiratory Distress Syndrome (ARDS). Edesa's drug candidates have shown promising clinical results and are designed to modulate pathways implicated in various immune-related diseases.Explore more
Edesa Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Edesa Biotech
Compare insights from companies similar to Edesa Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
b2/20220119085815okyddzEyf6.png){kind=small}
Edesa Biotech Tech Stack
A closer look at the technologies used by Edesa Biotech
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Edesa Biotech
Sign Up For FreeTo access detailed company insights
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing novel treatments for immune and inflammatory diseases. Their innovative monoclonal antibody candidates aim to address immune dysregulation through host-directed therapeutics. The company is dedicated to improving the lives of patients suffering from both acute a... Read More
